Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 18 studies | 24% ± 9% | |
| oligodendrocyte | 13 studies | 38% ± 15% | |
| endothelial cell of artery | 8 studies | 30% ± 13% | |
| endothelial cell of lymphatic vessel | 5 studies | 29% ± 8% | |
| vein endothelial cell | 4 studies | 20% ± 8% | |
| glutamatergic neuron | 4 studies | 30% ± 11% | |
| adipocyte | 4 studies | 21% ± 5% | |
| microglial cell | 3 studies | 21% ± 2% | |
| epithelial cell | 3 studies | 20% ± 6% | |
| endothelial cell of vascular tree | 3 studies | 28% ± 15% | |
| GABAergic neuron | 3 studies | 39% ± 8% | |
| astrocyte | 3 studies | 24% ± 2% | |
| oligodendrocyte precursor cell | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 7 studies | 31% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 100% | 3545.09 | 966 / 966 | 100% | 28.98 | 526 / 527 |
| stomach | 100% | 2371.90 | 358 / 359 | 100% | 29.39 | 286 / 286 |
| breast | 100% | 3423.26 | 459 / 459 | 98% | 18.12 | 1100 / 1118 |
| esophagus | 100% | 2525.83 | 1439 / 1445 | 97% | 23.10 | 177 / 183 |
| bladder | 100% | 3253.38 | 21 / 21 | 96% | 24.49 | 485 / 504 |
| thymus | 100% | 2952.33 | 653 / 653 | 96% | 13.56 | 578 / 605 |
| lung | 100% | 5644.06 | 577 / 578 | 94% | 14.81 | 1090 / 1155 |
| uterus | 100% | 3046.19 | 170 / 170 | 93% | 13.90 | 427 / 459 |
| brain | 98% | 2099.69 | 2588 / 2642 | 94% | 16.05 | 665 / 705 |
| prostate | 100% | 2308.62 | 244 / 245 | 90% | 9.00 | 451 / 502 |
| pancreas | 91% | 935.66 | 297 / 328 | 98% | 22.57 | 174 / 178 |
| kidney | 99% | 1967.73 | 88 / 89 | 85% | 11.43 | 762 / 901 |
| ovary | 70% | 871.23 | 126 / 180 | 87% | 9.55 | 373 / 430 |
| skin | 73% | 4575.60 | 1323 / 1809 | 81% | 8.92 | 384 / 472 |
| liver | 84% | 848.42 | 190 / 226 | 69% | 7.17 | 282 / 406 |
| adrenal gland | 94% | 1176.03 | 243 / 258 | 57% | 4.62 | 131 / 230 |
| adipose | 100% | 3316.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 25.89 | 29 / 29 |
| spleen | 100% | 4112.38 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 22.31 | 1 / 1 |
| heart | 100% | 2122.31 | 857 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 2100.36 | 1320 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 12.38 | 42 / 45 |
| muscle | 91% | 1287.40 | 727 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 40% | 1085.58 | 373 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 5% | 0.28 | 4 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0009267 | Biological process | cellular response to starvation |
| GO_0008150 | Biological process | biological_process |
| GO_0048015 | Biological process | phosphatidylinositol-mediated signaling |
| GO_1905037 | Biological process | autophagosome organization |
| GO_0036092 | Biological process | phosphatidylinositol-3-phosphate biosynthetic process |
| GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
| GO_0016477 | Biological process | cell migration |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005942 | Cellular component | phosphatidylinositol 3-kinase complex |
| GO_0030139 | Cellular component | endocytic vesicle |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0035091 | Molecular function | phosphatidylinositol binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0016303 | Molecular function | 1-phosphatidylinositol-3-kinase activity |
| GO_0035005 | Molecular function | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PIK3C2B |
| Protein name | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B variant protein PIK3C2B protein Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta Phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta (Phosphoinositide-3-kinase, class 2, beta polypeptide) |
| Synonyms | hCG_16410 protein variant |
| Description | FUNCTION: Phosphorylates PtdIns and PtdIns4P with a preference for PtdIns . Does not phosphorylate PtdIns(4,5)P2 . May be involved in EGF and PDGF signaling cascades . . |
| Accessions | B7ZM86 ENST00000367187.7 ENST00000684373.1 F5GWN5 Q5SW97 ENST00000424712.6 Q5SW98 ENST00000415899.2 O00750 A2RUF7 Q4LE65 Q5SWA0 ENST00000429009.1 ENST00000367184.2 |